Fibrous dysplasia

WikiDoc Resources for Fibrous dysplasia
Articles
Most recent articles on Fibrous dysplasia Most cited articles on Fibrous dysplasia Review articles on Fibrous dysplasia Articles on Fibrous dysplasia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Fibrous dysplasia Images of Fibrous dysplasia Photos of Fibrous dysplasia Podcasts & MP3s on Fibrous dysplasia Videos on Fibrous dysplasia
Evidence Based Medicine
Cochrane Collaboration on Fibrous dysplasia Bandolier on Fibrous dysplasia TRIP on Fibrous dysplasia
Clinical Trials
Ongoing Trials on Fibrous dysplasia at Clinical Trials.gov Trial results on Fibrous dysplasia Clinical Trials on Fibrous dysplasia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Fibrous dysplasia NICE Guidance on Fibrous dysplasia NHS PRODIGY Guidance FDA on Fibrous dysplasia CDC on Fibrous dysplasia
Books
Books on Fibrous dysplasia
News
Fibrous dysplasia in the news Be alerted to news on Fibrous dysplasia News trends on Fibrous dysplasia
Commentary
Blogs on Fibrous dysplasia
Definitions
Definitions of Fibrous dysplasia
Patient Resources / Community
Patient resources on Fibrous dysplasia Discussion groups on Fibrous dysplasia Patient Handouts on Fibrous dysplasia Directions to Hospitals Treating Fibrous dysplasia Risk calculators and risk factors for Fibrous dysplasia
Healthcare Provider Resources
Symptoms of Fibrous dysplasia Causes & Risk Factors for Fibrous dysplasia Diagnostic studies for Fibrous dysplasia Treatment of Fibrous dysplasia
Continuing Medical Education (CME)
CME Programs on Fibrous dysplasia
International
Fibrous dysplasia en Espanol Fibrous dysplasia en Francais
Business
Fibrous dysplasia in the Marketplace Patents on Fibrous dysplasia
Experimental / Informatics
List of terms related to Fibrous dysplasia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sunny Kumar MD [2]

Overview

Fibrous dysplasia [FD] is a disorder of bones which may occur with or without endocrinological and skin disorders. It may cause bony pain, deformity, fracture and / or entrapment of nerves, It is basically the acquired mis-sense mutation of gene coding for the α-subunit of the stimulatory G-protein, Gs, in the guanine nucleotide binding, alpha stimulating (GNAS) complex locus in chromosome 20q13. It leads to immature or poor differentiation of body tissue at the time of ossification and replacement of bone by fibrous tissue. Diagnosis depends on radiology and biopsic specimen.

Historical Perspective

• Fibrous dysplasia was first observed in bone radiography by Von Recklinghausen in 1891.
• It was then entitled as separate entity by american pathologist Dr. Louis Lichtenstein in 1938 as fibrous dysplasia polyostotic.
• In 1942, Dr Lichtenstein and Dr. Jaffe together labeled syndrome named McCune-Albright syndrome (fibrous dysplasia-café au lait spots-endocrine dysfunction) or Mazabraud syndrome (fibrous dysplasia-myxomas). 

Classification

• Fibrous dysplasia may be classified according to number of bony sites involved into two groups:

• One bone: monostotic fibrous dysplasia
• Multiple bones: polyostotic fibrous dysplasia

• Other variants of FD include:
  • McCune-Albright syndrome
  • Mazabraud syndrome

Pathophysiology

The pathophysiology of fibrous dysplasia is based on mechanism of G protein mutation.

Genetics

• The somatic mutation in GNAS1 gene located on the long arm (q) of chromosome 20 (20q13.2) has been associated with the development of FD, involving the gain-of-function mutation pathway.
• Mutation of GNAS1 gene is a somatic mutation and it is not heritable.
• The exact reason for post fertilization mutation remains unknown.
• Mutation of GNAS1 gene results in the overproduction of this G-protein, which in turn increases cyclic adenosine monophosphate (cAMP).
• Cyclic adenosine monophosphate (cAMP) is important regulatory molecule of differentiation modulating osteoblasts and osteoclasts while ossification and remodeling of bones.
• Improper differentiation of osteoblasts due to mutation of the GNAS1 gene considered as a cause of FD.
• Osteoclasts removes ossified bones and creates space for immature osteoblasts to produce fibrous tissue and occupy space which may entrap nerves causing pain or neurological deficit depending on the site involved.

Gross pathology

• Following are characteristic gross pathology findings of fibrous dysplasia:
  • Well circumscribed, intramedullary lesion
  • Tan-white-yellow, gritty, large lesions that distort bone
  • Thin and expanded cortical bone

Microscopic histopathological analysis

• Following are characteristic microscopic histopathological findings of fibrous dysplasia:
  • Curvilinear trabeculae (Chinese letters) of metaplastic woven bone
  • Hypocellular and fibroblastic stroma
  • No osteoblastic rimming (due to maturation arrest)
  • Cartilaginous nodules (in 20% of cases particularly in femoral neck region)
  • Myxoid areas consist of rapidly growing secondary aneurysmal bone cysts, hemorrhage, foamy macrophages, calcified spherules, and focal hyaline cartilage
  • Abrupt transition of normal to abnormal bone
  • No/rare mitotic figures
  • No atypia (rarely is degenerative)
  • Resembling endochondral ossification in skull

Differentiating Fibrous dyspepsia from other Diseases

• Fibrous dysplasia must be differentiated from other diseases that cause bone pain, deformity, and extra-skeletal involvement, such as:

Disease	Bone involvement	Bone pain	Fever	Fractures	Mechanisum	ALK levels	Diagnosis
ossifying sarcoma	single	yes	no	yes	neoplasm	normal	radiology and biopsy
paget's disease	multiple	yes	no	yes	malfunction of osteoblast	high	biopsy
osteosarcoma	single	yes	no	yes	neoplasm	normal	radiology and biopsy
cherubism	single	yes	no	no	malfunction of osteoblas	high	radiology and biopsy
hyperparathyroidisum	multiple	yes	yes	yes	high PTH	normal	hormone workup
solitary endocytosis	single	yes	no	no	neoplasm	normal	radiology and biopsy
osteoblastoma	single	yes	no	yes	neoplasm	high	radiology and biopsy
osteomyelitis	single	yes	yes	no	infection	normal	radiology and biopsy
brodie's abscess	single	yes	yes	no	infection	normal	radiology and biopsy

Epidemiology and Demographics

• The prevalence and incidence of fibrous dysplasia is not known exactly.

• FD is more commonly found in age group from 3 -15 years of life.
• Polyostotic does not become symptomatic before age 10 years.
• Monostotic is asymptomatic until age of 20-30 years of life.

• FD affects men and women equally.

• There is no racial predilection for FD.

Risk Factors

• Common risk factor in the development of fibrous dysplasia is gain-of-function mutation.

Natural History, Complications and Prognosis

• The majority of patients with FD remain asymptomatic for the first decade of life.
• Early clinical features include bone pain, bony deformity, fever, and pathological fractures.
• Patients with fibrous dysplasia might develop skin/endocrine/malignancies depending on the variant.
• Common complications of FD include neurological deficit, endocrine abnormality, and in rare cases soft tissue tumors.
• Prognosis is generally good, and the patients with polyostotic form may have frequent fractures.

Diagnosis

Diagnostic Criteria

• The diagnosis of FD is made on the basis of clinical manifestations, radiology findings, and genetic testing to verify presence of GNAS mutation.

Symptoms

• FD is usually asymptomatic.
• Symptoms of FD may include:
  • Fever
  • Bone pain
  • Bony deformity
  • Pathological fractures

Physical Examination

• Patients with FD usually appear normal unless there is any bony deformity or skin involvement
• Physical examination may be remarkable according to the classification of disease:

Monostotic

• Single bone involved.
• Mostly affects rib, femur, and tibia.
• Craniofacial bone and humerus bone
• Fracture at age of 10 years
• Less severe bone deformity
• Painless swelling of jaw
• Swelling of buccal and labial plate
• Protuberance of inferior border of mandible

Polyostotic

• Multiple bones involved
• Involve rib, femur, clavicle, lumbar spine, and tibia.
• Asymmetrical involvement
• Mainly misalignment of bones
• Tenderness over involved bone
• Bowing of weight bearing bone and increasing curvature of femur and tibia

Craniofacial

• Involvement of maxillofacial bones
• Maladjustment
• Tappering
• Displacement
• Intact over lesion
• Maxillary sinus and Zygomatic bone involved mostly
• Floor of orbit may extend to skull
• No extracranial involvement
• Hypertelorism, facial asymmetry, visual impairment, exophthalmos and blindness
• Vestibular dysfuntion, hearing loss and tinnitus.

McCune-Albright syndrome

• May involve all the bones
• Cafe au lait spots
• Endocrine abnormality of parathyroid hormone, gonadotropins Mazabraud syndrome
• Involve variable number of bones

Laboratory Findings

• There are no specific laboratory findings associated with FD. However, we may find normal PTH, Ca levels, and increased level of alkaline phosphatase due to increased bone turnover and increased basal metabolic rate.

Imaging Findings

• Radiology is the imaging modality of choice for FD.
• On x-ray, FD is characterized by:
  • Network of fine bone trabeculae
  • Increased trabeculation
  • Opaque trabeculation forming ground glass appearance
  • Cortical thinning
  • Separated root of teeth

Other Diagnostic Studies

• MRI and CT scan may be helpful in diagnosis of fibrous dysplasia.
• Bone biopsy will reveal the histological findings such as:
  • Curvilinear trabeculae (Chinese letters) of metaplastic woven bone
  • Hypocellular and fibroblastic stroma
  • No osteoblastic rimming (due to maturation arrest)
  • Cartilaginous nodules (in 20% of cases particularly in femoral neck region)
  • Myxoid areas consist of rapidly growing secondary aneurysmal bone cysts, hemorrhage, foamy macrophages, calcified spherules, and focal hyaline cartilage

Incidental finding

Dull, aching pain and subsequent radiographs

Full-body 99Tc-methylene diphosphonate bone scan

Typical thinning of the cortex without periosteal reaction with a matrix appearance Ground glass

If Yes no further studies

If no Bone Biopsy

Treatment

Treatment of FD is mostly symptomatic and it can be either medical or surgical depending on severity and presentation of disease.

Medical Therapy

• The mainstay of therapy for FD is bisphosphonates, which help in improving pain, slow down process of bone turnover, and also lower the fracture risk factor.
• Bisphosphonates acts by inhibiting osteoclasts.
• In the absence of a fracture or symptoms, the follow-up for a child with FD consists of twice yearly clinical evaluations with special attention to limited range of motion, obvious angular deformity, and limb length discrepancy.

Surgery

• Conventional surgical procedures can only be performed for patients with symptomatic FD patients in conjugation of over all evaluation of disease and the age of child.
• Adult monosteotic lesion may be observed with subsequent radiography if it is not symptomatic. surgical removal and grafting the defect is considered for patients who have symptoms or excessively growing deformity or when disease produces deficit.
• Child age group may have skin lesions and endocrinopathies which needs prompt attention and surgery will be delayed until bones are mature and in case of neurological defect or significant deformity surgery is advised immediately.